FDA Inspection 1266407 — Department of Defense - Army
The FDA completed an inspection of Department of Defense - Army on March 21, 2025 in Tripler Army Medical Center, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tripler Army Medical Center, HI (United States)